These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4188182)

  • 1. A morphological study on the mechanism of diazoxide-hyperglycemia (clinical and experimental investigation).
    Yoshinaga T
    Endokrinologie; 1969; 54(5):410-22. PubMed ID: 4188182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphology and histochemistry of insulin secretion].
    Creutzfelt W
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():387-416. PubMed ID: 4313827
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
    Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
    Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance.
    Creutzfeldt W; Arnold R; Creutzfeldt C; Deuticke U; Frerichs H; Track NS
    Diabetologia; 1973 Jun; 9(3):217-31. PubMed ID: 4351967
    [No Abstract]   [Full Text] [Related]  

  • 5. Diazoxide-induced long-term hyperglycemia. I. Preservation of B-cell insulin-releasing capacity.
    Gomis R; Plaza C; Malaisse WJ
    Diabetes Res; 1988 Dec; 9(4):183-6. PubMed ID: 3073904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of diazoxide in children with islet cell adenomas.
    Castro A; Dyess K; Buist N; Potts J
    Clin Biochem; 1973 Sep; 6(3):211-9. PubMed ID: 4355570
    [No Abstract]   [Full Text] [Related]  

  • 7. An ultrastructural study of the islet cell tumor of the golden hamster.
    Amherdt M; Orci L; Track NS; Lambert AE; Kanazawa Y; Stauffacher W
    Horm Metab Res; 1971 Jul; 3(4):252-8. PubMed ID: 4331701
    [No Abstract]   [Full Text] [Related]  

  • 8. Giant islet cell tumor of the pancreas with alpha-like granules. An ultrastructural study.
    Jacob ET; Golan M; Griffel B; Deutsch V
    Isr J Med Sci; 1973 Aug; 9(8):1028-35. PubMed ID: 4356728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histology, histochemistry and ultrastructure of islet tumors].
    Tardini A; Bordi C
    Arch De Vecchi Anat Patol; 1968 Mar; 51(1):1-36. PubMed ID: 4311262
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on diazoxide-induced hyperglycemia: an extrapancreatic mechanism.
    Bleicher SJ; Chowdhury F; Podolsky S; Fleishman P; Goldner MG
    Ann N Y Acad Sci; 1968 Apr; 150(2):294-302. PubMed ID: 4299221
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
    Loubatières A; Mariani MM; Alric R
    Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
    [No Abstract]   [Full Text] [Related]  

  • 12. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
    Song SH; Rhodes CJ; Veldhuis JD; Butler PC
    Endocrinology; 2003 Aug; 144(8):3399-405. PubMed ID: 12865318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staining reactions in an islet cell carcinoma of - 2 -type.
    Grimelius L; Petersson B; Lundquist G; Dahlgren S; Parrow A
    Acta Soc Med Ups; 1971; 76(1-2):49-57. PubMed ID: 4109135
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical aspects of the hyperglycemic action of diazoxide.
    Senft G
    Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetogenic activity of diazoxide].
    Zahnd GR; Luyckx A
    Helv Med Acta Suppl; 1966 May; 46():163. PubMed ID: 5286273
    [No Abstract]   [Full Text] [Related]  

  • 16. Diazoxide.
    Br Med J; 1972 Nov; 4(5837):417-8. PubMed ID: 4344353
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man.
    Graber AL; Porte D; Williams RH
    Ann N Y Acad Sci; 1968 Apr; 150(2):303-8. PubMed ID: 4299222
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanism of sensitivity to leucine in the case of "leucine sensitive hypoglycemia". (I).
    Yoshinaga T; Hidaka J
    Endokrinologie; 1969; 54(1):118-33. PubMed ID: 4311610
    [No Abstract]   [Full Text] [Related]  

  • 19. Diazoxide unmasks glucose inhibition of insulin release by counteracting entry of Ca2+.
    Bergsten P; Gylfe E; Wesslén N; Hellman B
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E422-7. PubMed ID: 3052102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
    Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
    Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.